Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of Euro1.25 Million Following First Commercial Sale of Pliaglis by Cantabria in Italy

Stock Information for Crescita Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.